| http://dbpedia.org/ontology/abstract
|
SRX246, also known as API-246, is a small- … SRX246, also known as API-246, is a small-molecule, centrally-active, highly-selective vasopressin V1A receptor antagonist which is under investigation by Azevan Pharmaceuticals for the treatment of affective and anger disorders. It is an azetidinone derivative, and was developed from LY-307174 as a lead compound. A phase II activity trial of the drug in the treatment of adults with intermittent explosive disorder is ongoing. It is also being studied for the treatment of post-traumatic stress disorder.eatment of post-traumatic stress disorder.
|
| http://dbpedia.org/ontology/casNumber
|
512784-93-9
|
| http://dbpedia.org/ontology/fdaUniiCode
|
372X2P22UY
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/SRX246.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://adisinsight.springer.com/drugs/800023656 +
, http://www.azevan.com/pipeline/default.asp +
|
| http://dbpedia.org/ontology/wikiPageID
|
45643855
|
| http://dbpedia.org/ontology/wikiPageLength
|
4883
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
984414907
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Post-traumatic_stress_disorder +
, http://dbpedia.org/resource/Category:Lactams +
, http://dbpedia.org/resource/List_of_investigational_anxiolytics +
, http://dbpedia.org/resource/Anger_disorder +
, http://dbpedia.org/resource/Category:Oxazolidines +
, http://dbpedia.org/resource/Intermittent_explosive_disorder +
, http://dbpedia.org/resource/Central_nervous_system +
, http://dbpedia.org/resource/Affective_disorder +
, http://dbpedia.org/resource/TS-121 +
, http://dbpedia.org/resource/Nelivaptan +
, http://dbpedia.org/resource/Category:Piperidines +
, http://dbpedia.org/resource/ABT-436 +
, http://dbpedia.org/resource/Azetidinone +
, http://dbpedia.org/resource/Category:Vasopressin_receptor_antagonists +
, http://dbpedia.org/resource/Small-molecule +
, http://dbpedia.org/resource/Arginine_vasopressin_receptor_1A +
, http://dbpedia.org/resource/Receptor_antagonist +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Balovaptan +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/c
|
42
|
| http://dbpedia.org/property/casNumber
|
512784
|
| http://dbpedia.org/property/chemspiderid
|
23290398
|
| http://dbpedia.org/property/h
|
49
|
| http://dbpedia.org/property/iupacName
|
-4
|
| http://dbpedia.org/property/n
|
5
|
| http://dbpedia.org/property/o
|
5
|
| http://dbpedia.org/property/smiles
|
O=C1[C@@H][C@@H]N1[C@@H]CC=O
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
FJUKOXWSIGULLE-JVOQCOEYSA-N
|
| http://dbpedia.org/property/unii
|
372
|
| http://dbpedia.org/property/width
|
250
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Oxytocin_and_vasopressin_receptor_modulators +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Lactams +
, http://dbpedia.org/resource/Category:Piperidines +
, http://dbpedia.org/resource/Category:Oxazolidines +
, http://dbpedia.org/resource/Category:Vasopressin_receptor_antagonists +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/V +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/SRX246?oldid=984414907&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/SRX246.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/SRX246 +
|
| owl:sameAs |
http://dbpedia.org/resource/SRX246 +
, http://rdf.freebase.com/ns/m.012zywlc +
, http://www.wikidata.org/entity/Q21098891 +
, http://yago-knowledge.org/resource/SRX246 +
, https://global.dbpedia.org/id/zTje +
|
| rdf:type |
http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/MeanOfTransportation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
SRX246, also known as API-246, is a small- … SRX246, also known as API-246, is a small-molecule, centrally-active, highly-selective vasopressin V1A receptor antagonist which is under investigation by Azevan Pharmaceuticals for the treatment of affective and anger disorders. It is an azetidinone derivative, and was developed from LY-307174 as a lead compound. A phase II activity trial of the drug in the treatment of adults with intermittent explosive disorder is ongoing. It is also being studied for the treatment of post-traumatic stress disorder.eatment of post-traumatic stress disorder.
|
| rdfs:label |
SRX246
|
